DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Brannagan III TH, Patterson SK.
Alemtuzumab: the future of chronic inflammatory demyelinating polyradiculoneuropathy treatment?.
Expert Rev Clin Immunol 2010;
6 (3) 319-321
We do not assume any responsibility for the contents of the web pages of other providers.